Version 2.78

Description

The GALAD model is a statistical model for estimating the likelihood of hepatocellular carcinoma (HCC) in patients with chronic liver disease. The GALAD score is calculated based on gender, age, and concentrations of AFL-L3, AFP, and des-gamma-carboxy prothrombin (DCP). The GALAD model has been demonstrated to have higher diagnostic accuracy for the detection of HCC compared to these individual markers alone or in combination, as well as reported to be superior to ultrasound for HCC detection PMID: 30464023. Source: Regenstrief LOINC

Basic Part Properties

Part Display Name
GALAD
Part Type
Method (Describes the method by which the test was performed)
Created On
2020-11-25
Construct for LOINC Short Name
GALAD

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP421438-5

Language Variants Get Info

Tag Language Translation
it-IT Italian (Italy) GALAD
zh-CN Chinese (China) GALAD
Synonyms: 性别、年龄、甲胎蛋白（AFP、alpha-fetoprotein、α-胎儿球蛋白）-L3、甲胎蛋白（AFP、alpha-fetoprotein、α-胎儿球蛋白）和脱-γ-羧基凝血酶原（DCP、异常凝血酶原、PIVKA-II、维生素K缺乏或拮抗剂-II诱导的蛋白、Protein Induced by Vitamin K Absence or Antagonist-II）;GALAD 法;Gender, Age, Alpha-fetoprotein (AFP)-L3, AFP, and Des-gamma-c
es-ES Spanish (Spain) GALAD